Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.
Kaposi's sarcoma-associated herpesvirus (KSHV) DNA persists in latently infected cells as an episome via tethering to the host chromosomes. The latency-associated nuclear antigen (LANA) of KSHV binds to the cis-acting elements in the terminal repeat (TR) region of the genome through its carboxy terminus. Previous studies have demonstrated that LANA is important for episome maintenance and replication of the TR-containing plasmids. Here we report that LANA associates with origin recognition complexes (ORCs) when bound to its 17-bp LANA binding cognate sequence (LBS). Chromatin immunoprecipitation of multiple regions across the entire genome from two KSHV-infected cell lines, BC-3 and BCBL-1, revealed that the ORCs predominantly associated with the chromatin structure at the TR as well as two regions within the long unique region of the genome. Coimmunoprecipitation of ORCs with LANA-specific antibodies shows that ORCs can bind and form complexes with LANA in cells. This association was further supported by in vitro binding studies which showed that ORCs associate with LANA predominantly through the carboxy-terminal DNA binding region. KSHV-positive BC-3 and BCBL-1 cells arrested in G(1)/S phase showed colocalization of LANA with ORCs. Furthermore, replication of The TR-containing plasmid required both the N- and C termini of LANA in 293 and DG75 cells. Interestingly, our studies did not detect cellular ORCs associated with packaged viral DNA as an analysis of purified virions did not reveal the presence of ORCs, minichromosome maintenance proteins, or LANA.
Verma
Subhash C
SC
Department of Microbiology and Tumor Virology Program of the Abramson Comprehensive Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Choudhuri
Tathagata
T
Kaul
Rajeev
R
Robertson
Erle S
ES
D000956:Antigens, Viral / Q000378:metabolism*; D015153:Blotting, Western; D002460:Cell Line; D002467:Cell Nucleus / Q000737:chemistry; D002843:Chromatin / Q000302:isolation & purification; D024202:Electrophoretic Mobility Shift Assay; D019288:Herpesvirus 8, Human / Q000502:physiology*; D006801:Humans; D047468:Immunoprecipitation; D018613:Microscopy, Confocal; D008958:Models, Molecular; D009687:Nuclear Proteins / Q000378:metabolism*; D051738:Origin Recognition Complex / Q000378:metabolism*; D011485:Protein Binding; D011506:Proteins / Q000032:analysis; D020079:Terminal Repeat Sequences / Q000502:physiology*; D014764:Viral Proteins / Q000032:analysis
D000956:Antigens, Viral; D002843:Chromatin; D009687:Nuclear Proteins; D051738:Origin Recognition Complex; D011506:Proteins; D014764:Viral Proteins; C109540:latency-associated nuclear antigen